著者

Rei Haruyama Hiromi Obara Noriko Fujita

出版者

National Center for Global Health and Medicine

雑誌

Global Health & Medicine (ISSN:24349186)

巻号頁・発行日

pp.2020.01070, (Released:2020-09-30)

参考文献数

20

被引用文献数

3

---

Following the global call to action by the World Health Organization (WHO), the world is currently moving to eliminate cervical cancer as a public health problem. To eliminate the cancer within this century, which is defined as an age-adjusted cervical cancer incidence rate (ASIR) below 4 per 100,000 women, WHO recommends all countries to achieve "90-70-90" targets for human papilloma virus (HPV) vaccination, cervical cancer screening, and treatment of precancer and cancer by 2030. In Japan, ASIR has been rising since the late 1990s to 11.1 per 100,000 women, and this rise is particularly prominent in women of reproductive age. HPV vaccination coverage is as low as 0.3%, largely due to the Government’s ongoing suspension of proactive recommendations for the vaccine. Given the absence of centralized, population-based cervical cancer screening program and a nationwide surveillance system for systematic monitoring, the exact screening participation rate and treatment rate are difficult to estimate. A national survey suggested that only around 40% of women between the ages of 20 and 69 years underwent cervical cancer screening within the last two years. National policies and systems for HPV vaccination and screening should be updated in a more efficient way as new evidence and innovations become available. In the wake of powerful global momentum, actions must be taken now to further enhance cervical cancer control and ensure that Japanese girls and women are no longer left behind.

著者

Aya Tanaka Linka Koun Rei Haruyama Kyna Uy Maryan Chhit Lumpiny Kim Noriko Fujita Yutaka Osuga Tadashi Kimura Kanal Koum

出版者

National Center for Global Health and Medicine

雑誌

GHM Open (ISSN:2436293X)

巻号頁・発行日

pp.2023.01002, (Released:2023-06-18)

参考文献数

21

---

The clinical features of newly diagnosed cervical cancer in Cambodia are poorly documented. We aimed to describe the histologic type and stage distributions of newly diagnosed cervical cancer patients at the Khmer Soviet Friendship Hospital in Phnom Penh, which is one of the two national cancer centers in Cambodia. A descriptive cross-sectional study was conducted using the Gynecologic Test Registry of the gynecology department between January and December 2019. In 2019, 351 women were histologically diagnosed with cervical cancer, representing approximately one-third of the estimated total cases occurring in the country. The mean age at presentation was 54.7 years. The histologic type distribution was largely consistent with other Asian countries, with squamous cell carcinoma accounting for 83.8%, followed by adenocarcinoma (15.4%). Among 309 patients with recorded staging information, 57.6% were advanced-stage cancers (i.e. stage IIB or higher). Raising awareness of early symptoms of cervical cancer, increasing access to cancer diagnosis, and better recording of patients’ clinical information are important to improve cervical cancer management in Cambodia.